CoChat

Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease

Open access
Khan, Shahzad S., Jaimon, Ebsy, Lin, Yu-En, Nikoloff, Jonas, Tonelli, Francesca, Alessi, Dario R., Pfeffer, Suzanne R. · 2024 · Proceedings of the National Academy of Sciences

Published version of a preprint

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Activating leucine-rich repeat kinase 2 (LRRK2) mutations cause Parkinson’s and phosphorylation of Rab10 by pathogenic LRRK2 blocks primary ciliogenesis in cultured cells. In the mouse brain, LRRK2 blockade of primary cilia is highly cell type specific: For example, cholinergic interneurons and astrocytes but not medium spiny neurons of the dorsal striatum lose primary cilia in LRRK2-pathway mutant mice. We show here that the cell type specificity of LRRK2-mediated cilia loss is also seen in human postmortem striatum from patients with LRRK2 pathway mutations and idiopathic Parkinson’s. Single nucleus RNA sequencing shows that cilia loss in mouse cholinergic interneurons is accompanied by decreased glial-derived neurotrophic factor transcription, decreasing neuroprotection for dopamine neurons. Nevertheless, LRRK2 expression differences cannot explain the unique vulnerability of cholinergic neurons to LRRK2 kinase as much higher LRRK2 expression is seen in medium spiny neurons that have normal cilia. In parallel with decreased striatal dopaminergic neurite density, LRRK2 G2019S neurons show increased autism-linked CNTN5 adhesion protein expression; glial cells show significant loss of ferritin heavy chain. These data strongly suggest that loss of cilia in specific striatal cell types decreases neuroprotection for dopamine neurons in mice and human Parkinson’s.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2402206121

Cites

66 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Single nucleus RNA sequencing analysis of WT mouse dorsal striatum. (A) tSNE plot showing cell types detected using markers summarized in SI Appendix, Table S1. (B) RNAScope in situ hybridization to detect LRRK2 transcripts in the dorsal striatum. Green, anti-choline acetyltransferase staining of a cholinergic interneuron surrounded by the much more abundant medium spiny neurons; pink, primary cilia; yellow dots, LRRK2 transcripts, blue, DAPI stained nuclei. Bar, 10 µm. (C and D) Comparison of relative LRRK2 (C) or PPM1H (D) RNA levels in cell types color coded as in A.
Fig. 1. Single nucleus RNA sequencing analysis of WT mouse dorsal striatum. (A) tSNE plot showing cell types detected using markers summarized in SI Appendix, Table S1. (B) RNAScope in situ hybridization to detect LRRK2 transcripts in the dorsal striatum. Green, anti-choline acetyltransferase staining of a cholinergic interneuron surrounded by the much more abundant medium spiny neurons; pink, primary cilia; yellow dots, LRRK2 transcripts, blue, DAPI stained nuclei. Bar, 10 µm. (C and D) Comparison of relative LRRK2 (C) or PPM1H (D) RNA levels in cell types color coded as in A.CC BY · PubMed Central
Fig. 2. Two classes of cells explain ciliation differences in cholinergic interneurons in the dorsal striatum. (A) Single nucleus RNA sequencing analysis of cholinergic interneurons from WT mouse dorsal striatum. Cholinergic interneurons subclustered according to the markers indicated. Relative LRRK2 and PPM1H expression is shown at the Right for all subclusters with purple intensity reflecting abundance in that nucleus. (B and C) RNAScope in situ hybridization analysis of LRRK2 RNA (white dots in B) in cholinergic interneurons according to ciliation status in 2.5-mo-old WT or PPM1H KO dorsal striatum. Error bars in C represent SEM from 4 WT and 4 PPM1H KO brains, with >25 ChAT+ neurons scored per brain. Statistical significance was determined using an unpaired t test: ****P < 0.0001 for ciliated WT versus unciliated WT; ****P < 0.0001 for ciliated PPM1H KO versus unciliated PPM1H KO. (D) Comparison of GDNF expression from RNAseq data between WT and G2019S KI cholinergic interneurons. Statistical significance was determined using a student’s t test. ****P < 0.0001.
Fig. 2. Two classes of cells explain ciliation differences in cholinergic interneurons in the dorsal striatum. (A) Single nucleus RNA sequencing analysis of cholinergic interneurons from WT mouse dorsal striatum. Cholinergic interneurons subclustered according to the markers indicated. Relative LRRK2 and PPM1H expression is shown at the Right for all subclusters with purple intensity reflecting abundance in that nucleus. (B and C) RNAScope in situ hybridization analysis of LRRK2 RNA (white dots in B) in cholinergic interneurons according to ciliation status in 2.5-mo-old WT or PPM1H KO dorsal striatum. Error bars in C represent SEM from 4 WT and 4 PPM1H KO brains, with >25 ChAT+ neurons scored per brain. Statistical significance was determined using an unpaired t test: ****P < 0.0001 for ciliated WT versus unciliated WT; ****P < 0.0001 for ciliated PPM1H KO versus unciliated PPM1H KO. (D) Comparison of GDNF expression from RNAseq data between WT and G2019S KI cholinergic interneurons. Statistical significance was determined using a student’s t test. ****P < 0.0001.CC BY · PubMed Central
Fig. 3. Spatial distribution of LRRK2 (Left column) and GRM5 RNA (Right column) levels in mouse dorsal striatal cholinergic interneurons. Top row: representative tile scan images of mouse dorsal striatum from 2.5-mo-old WT mice. Cholinergic interneurons were labeled using anti-ChAT antibody (green) and LRRK2 RNA or GRM5 RNA (yellow dots) were detected using RNAScope in situ hybridization. Nuclei were labeled using DAPI (blue). Inset at Upper Left shows an example of an enlarged cholinergic interneuron and its LRRK2 RNA content (yellow dots) used to quantify expression summarized in lower rows. Middle row: Spatial heat maps of LRRK2 RNA (Left) and GRM5 RNA (Right) in cholinergic interneurons. Each dot represents one cholinergic interneuron color coded based on RNA expression. Red intensity is used to indicate number of RNAScope dots in each cell. Bottom row: Same as in Middle row except that Black dots represent cholinergic interneurons with high LRRK2 (>5 dots per cell) or high GRM5 (≥7 dots per cell) and white dots represent cholinergic interneurons with low LRRK2 (≤5 dots per cell) or low GRM5 (<7 dots per cell). (Bar, 200 µm.)
Fig. 3. Spatial distribution of LRRK2 (Left column) and GRM5 RNA (Right column) levels in mouse dorsal striatal cholinergic interneurons. Top row: representative tile scan images of mouse dorsal striatum from 2.5-mo-old WT mice. Cholinergic interneurons were labeled using anti-ChAT antibody (green) and LRRK2 RNA or GRM5 RNA (yellow dots) were detected using RNAScope in situ hybridization. Nuclei were labeled using DAPI (blue). Inset at Upper Left shows an example of an enlarged cholinergic interneuron and its LRRK2 RNA content (yellow dots) used to quantify expression summarized in lower rows. Middle row: Spatial heat maps of LRRK2 RNA (Left) and GRM5 RNA (Right) in cholinergic interneurons. Each dot represents one cholinergic interneuron color coded based on RNA expression. Red intensity is used to indicate number of RNAScope dots in each cell. Bottom row: Same as in Middle row except that Black dots represent cholinergic interneurons with high LRRK2 (>5 dots per cell) or high GRM5 (≥7 dots per cell) and white dots represent cholinergic interneurons with low LRRK2 (≤5 dots per cell) or low GRM5 (<7 dots per cell). (Bar, 200 µm.)CC BY · PubMed Central
Fig. 4. (A) Volcano plot analysis comparing transcripts that increase (Right side) or decrease (Left side) in LRRK2 G2019S dorsal striatal neurons compared with age-matched WT mouse controls. Dashed vertical lines represent the Log2 fold change cutoff (between −0.2 and 0.2). The dashed horizontal line represents the adjusted P value cutoff (less than 0.05). The cell type analyzed is indicated at the Top of each graph. Number of variables for direct spiny projection neurons (7,699), indirect spiny projection neurons (7,213), eccentric spiny projection neurons (8,212), and parvalbumin interneurons (9,270). (B) Immunofluorescence microscopy of cells stained with antibodies to detect NeuN (green), DRD2 (blue), and CNTN5 (red) expression. Total fluorescence intensity of CNTN5 within 5 pixels of the NeuN or DRD2 was quantified and normalized to either total NeuN staining or total DRD2 staining. Error bars represent SEM from 4 WT and 4 G2019S brains, with >365 NeuN+ neurons and >200 DRD2+ neurons scored per brain. Statistical significance was determined using an unpaired t test. CNTN5 intensity in NeuN+ neurons: *P = 0.0184 for WT versus G2019S and CNTN5 intensity in DRD2+ neurons: *P = 0.0177 for WT versus G2019S. (Bar, 10 µm.) Detailed precise data can be found in Dataset S1.
Fig. 4. (A) Volcano plot analysis comparing transcripts that increase (Right side) or decrease (Left side) in LRRK2 G2019S dorsal striatal neurons compared with age-matched WT mouse controls. Dashed vertical lines represent the Log2 fold change cutoff (between −0.2 and 0.2). The dashed horizontal line represents the adjusted P value cutoff (less than 0.05). The cell type analyzed is indicated at the Top of each graph. Number of variables for direct spiny projection neurons (7,699), indirect spiny projection neurons (7,213), eccentric spiny projection neurons (8,212), and parvalbumin interneurons (9,270). (B) Immunofluorescence microscopy of cells stained with antibodies to detect NeuN (green), DRD2 (blue), and CNTN5 (red) expression. Total fluorescence intensity of CNTN5 within 5 pixels of the NeuN or DRD2 was quantified and normalized to either total NeuN staining or total DRD2 staining. Error bars represent SEM from 4 WT and 4 G2019S brains, with >365 NeuN+ neurons and >200 DRD2+ neurons scored per brain. Statistical significance was determined using an unpaired t test. CNTN5 intensity in NeuN+ neurons: *P = 0.0184 for WT versus G2019S and CNTN5 intensity in DRD2+ neurons: *P = 0.0177 for WT versus G2019S. (Bar, 10 µm.) Detailed precise data can be found in Dataset S1.CC BY · PubMed Central
Fig. 5. Loss of tyrosine hydroxylase and GDNF receptor staining in mouse G2019S LRRK2 dorsal striatum. Top panels: Confocal images of tissue labeled with anti-Tyrosine hydroxylase antibodies (green) and anti-GDNF receptor alpha-1 antibodies (magenta) in sections of the dorsal striatum from 5-mo-old WT or G2019S LRRK2 KI mice; blue stain in the merge image, NeuN. Unidentified tissue samples were stained and imaged at the same time; images were normalized by NeuN staining intensity but required very little normalization. Bottom graphs: Integrated intensity of Tyrosine hydroxylase and GDNF receptor α-1 was quantified using CellProfiler. Error bars represent SEM from 4 WT and 4 G2019S brains, with >25 fields scored per brain. Statistical significance was determined using an unpaired t test. Intensity of Tyrosine hydroxylase: ***P = 0.0001 for WT versus G2019S, Intensity of GDNF receptor α-1: ****P < 0.0001 for WT versus G2019S and intensity of GDNF receptor α-1/Tyrosine Hydroxylase: **P = 0.0034 for WT versus G2019S. (Bar, 10 µm.)
Fig. 5. Loss of tyrosine hydroxylase and GDNF receptor staining in mouse G2019S LRRK2 dorsal striatum. Top panels: Confocal images of tissue labeled with anti-Tyrosine hydroxylase antibodies (green) and anti-GDNF receptor alpha-1 antibodies (magenta) in sections of the dorsal striatum from 5-mo-old WT or G2019S LRRK2 KI mice; blue stain in the merge image, NeuN. Unidentified tissue samples were stained and imaged at the same time; images were normalized by NeuN staining intensity but required very little normalization. Bottom graphs: Integrated intensity of Tyrosine hydroxylase and GDNF receptor α-1 was quantified using CellProfiler. Error bars represent SEM from 4 WT and 4 G2019S brains, with >25 fields scored per brain. Statistical significance was determined using an unpaired t test. Intensity of Tyrosine hydroxylase: ***P = 0.0001 for WT versus G2019S, Intensity of GDNF receptor α-1: ****P < 0.0001 for WT versus G2019S and intensity of GDNF receptor α-1/Tyrosine Hydroxylase: **P = 0.0034 for WT versus G2019S. (Bar, 10 µm.)CC BY · PubMed Central
Fig. 6. Volcano plot analysis comparing transcripts that increase (Right side) or decrease (Left side) in LRRK2 G2019S dorsal striatal astrocytes, oligodendrocytes, or microglia compared with age-matched WT mouse controls. Dashed vertical lines represent the Log2 fold change cutoff (between −0.2 and 0.2). The dashed horizontal line represents the adjusted P value cutoff (less than 0.05). Upper Left, t-SNE representation of single nucleus RNA sequencing of astrocytes from WT mouse dorsal striatum, subclustered according to the markers indicated. Each cell type analyzed is indicated at the Top of each volcano plot. Number of genes for total astrocytes (4,791), GFAP+ astrocytes (4,463), ALDH1A1+ astrocytes (4,901), CRYM+ astrocytes (4,027), NRG1+ astrocytes (4,011), Oligodendrocytes (3,522 genes), and Microglia (3,606). Detailed precise data can be found in Dataset S1.
Fig. 6. Volcano plot analysis comparing transcripts that increase (Right side) or decrease (Left side) in LRRK2 G2019S dorsal striatal astrocytes, oligodendrocytes, or microglia compared with age-matched WT mouse controls. Dashed vertical lines represent the Log2 fold change cutoff (between −0.2 and 0.2). The dashed horizontal line represents the adjusted P value cutoff (less than 0.05). Upper Left, t-SNE representation of single nucleus RNA sequencing of astrocytes from WT mouse dorsal striatum, subclustered according to the markers indicated. Each cell type analyzed is indicated at the Top of each volcano plot. Number of genes for total astrocytes (4,791), GFAP+ astrocytes (4,463), ALDH1A1+ astrocytes (4,901), CRYM+ astrocytes (4,027), NRG1+ astrocytes (4,011), Oligodendrocytes (3,522 genes), and Microglia (3,606). Detailed precise data can be found in Dataset S1.CC BY · PubMed Central
Fig. 7. Loss of primary cilia in human cholinergic neurons but not medium spiny neurons from postmortem lenticular nucleus brain sections from PD patients and age-matched controls. (A) Confocal microscopy of tissue labeled with anti-ChAT antibody (green) and anti-AC3 antibody (magenta) to identify primary cilia. (B) Quantitation of the percentage of ChAT+ neurons containing a cilium. Error bars represent SEM from 7 Control, 3 G2019S, 8 sporadic PD, and 1 PPM1H mutation brains, with >30 ChAT+ neurons scored. Statistical significance was determined using one-way ANOVA. ***P = 0.0002 for Control versus G2019S PD and ****P < 0.0001 for Control versus Sporadic PD. (Bar, 10 µm.) (C) Confocal microscopy of human lenticular nucleus tissue labeled with anti-DARPP-32 antibody (green) to label medium spiny neurons and anti-AC3 antibody (magenta) to identify primary cilia. (D) Quantitation of the percentage of DARPP32+ neurons containing a cilium. Error bars represent SEM from 4 Control, 3 G2019S, 3 sporadic PD, and 1 PPM1H mutation brains, with >60 DARPP32+ neurons scored. All samples were scored blind and evaluated by at least two independent scientists. (Bar, 10 µm.)
Fig. 7. Loss of primary cilia in human cholinergic neurons but not medium spiny neurons from postmortem lenticular nucleus brain sections from PD patients and age-matched controls. (A) Confocal microscopy of tissue labeled with anti-ChAT antibody (green) and anti-AC3 antibody (magenta) to identify primary cilia. (B) Quantitation of the percentage of ChAT+ neurons containing a cilium. Error bars represent SEM from 7 Control, 3 G2019S, 8 sporadic PD, and 1 PPM1H mutation brains, with >30 ChAT+ neurons scored. Statistical significance was determined using one-way ANOVA. ***P = 0.0002 for Control versus G2019S PD and ****P < 0.0001 for Control versus Sporadic PD. (Bar, 10 µm.) (C) Confocal microscopy of human lenticular nucleus tissue labeled with anti-DARPP-32 antibody (green) to label medium spiny neurons and anti-AC3 antibody (magenta) to identify primary cilia. (D) Quantitation of the percentage of DARPP32+ neurons containing a cilium. Error bars represent SEM from 4 Control, 3 G2019S, 3 sporadic PD, and 1 PPM1H mutation brains, with >60 DARPP32+ neurons scored. All samples were scored blind and evaluated by at least two independent scientists. (Bar, 10 µm.)CC BY · PubMed Central
Fig. 8. Loss of primary cilia in striatal astrocytes from postmortem brain lenticular nucleus sections from PD patients. Left panels. Confocal images of astrocytes labeled using anti-GFAP (green) and primary cilia labeled using anti-Arl13b (magenta). Nuclei were labeled using DAPI (blue). Right panels. Quantitation of the percentage of GFAP+ astrocytes containing a cilium. Error bars represent SEM from 6 Control, 3 G2019S, 6 sporadic PD, and 1 PPM1H mutation brains, with >30 GFAP+ astrocytes scored. All samples were scored blind and evaluated by at least two independent scientists. Statistical significance was determined using one-way ANOVA. ****P < 0.0001 for Control versus G2019S and ****P < 0.0001 for Control versus Sporadic PD. (Bar, 10 µm.)
Fig. 8. Loss of primary cilia in striatal astrocytes from postmortem brain lenticular nucleus sections from PD patients. Left panels. Confocal images of astrocytes labeled using anti-GFAP (green) and primary cilia labeled using anti-Arl13b (magenta). Nuclei were labeled using DAPI (blue). Right panels. Quantitation of the percentage of GFAP+ astrocytes containing a cilium. Error bars represent SEM from 6 Control, 3 G2019S, 6 sporadic PD, and 1 PPM1H mutation brains, with >30 GFAP+ astrocytes scored. All samples were scored blind and evaluated by at least two independent scientists. Statistical significance was determined using one-way ANOVA. ****P < 0.0001 for Control versus G2019S and ****P < 0.0001 for Control versus Sporadic PD. (Bar, 10 µm.)CC BY · PubMed Central
Fig. 9. Loss of cholinergic neurons in the dorsal striatum of mice and lenticular nucleus of Parkinson’s patients. (A) Representative tile scan images of the mouse dorsal striatum from 5-mo-old WT or G2019S LRRK2 KI mice. Cholinergic interneurons were labeled using anti-ChAT (green). (B) Quantitation of mouse ChAT+ neurons detected per sq mm. Error bars represent SEM from 4 WT and 4 G2019S brains, with 4 sections scored per mouse. (C) Representative tile scan images of the lenticular nucleus from postmortem brain sections from PD patients, identified geographically and molecularly using anti-DARPP-32 antibodies; cholinergic interneurons were labeled using anti-ChAT antibodies (green). (D) Quantitation of human ChAT+ neurons detected per sq mm. Error bars represent SEM from 4 Control, 3 genetic PD, 8 sporadic PD, and 1 PPM1H mutated brains, with >100 tiles scored per brain. Areas boxed with dashed lines are enlarged and shown. Statistical significance was determined using one-way ANOVA. ****P < 0.0001 for Control versus G2019S and ****P < 0.0001 for Control versus Sporadic PD. (Bar, 100 µm.)
Fig. 9. Loss of cholinergic neurons in the dorsal striatum of mice and lenticular nucleus of Parkinson’s patients. (A) Representative tile scan images of the mouse dorsal striatum from 5-mo-old WT or G2019S LRRK2 KI mice. Cholinergic interneurons were labeled using anti-ChAT (green). (B) Quantitation of mouse ChAT+ neurons detected per sq mm. Error bars represent SEM from 4 WT and 4 G2019S brains, with 4 sections scored per mouse. (C) Representative tile scan images of the lenticular nucleus from postmortem brain sections from PD patients, identified geographically and molecularly using anti-DARPP-32 antibodies; cholinergic interneurons were labeled using anti-ChAT antibodies (green). (D) Quantitation of human ChAT+ neurons detected per sq mm. Error bars represent SEM from 4 Control, 3 genetic PD, 8 sporadic PD, and 1 PPM1H mutated brains, with >100 tiles scored per brain. Areas boxed with dashed lines are enlarged and shown. Statistical significance was determined using one-way ANOVA. ****P < 0.0001 for Control versus G2019S and ****P < 0.0001 for Control versus Sporadic PD. (Bar, 100 µm.)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 66

Metadata

Authors
Khan, S. S., Jaimon, E., Lin, Y.-E., Nikoloff, J., Tonelli, F., Alessi, D. R., & Pfeffer, S. R.
Affiliations
  • Stanford Medicine (US)
  • University of Dundee (GB)
Corresponding author
  • Khan, Shahzad S.
  • Jaimon, Ebsy
  • Pfeffer, Suzanne R.
Venue
Proceedings of the National Academy of Sciences
Published
2024-08
Volume
121
Issue
32
Pages
e2402206121-e2402206121
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4401213995
Cited by
61
References
66
Citations by year
2026: 25 · 2025: 23 · 2024: 12
FWCI
15.98
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (acceptedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
Funders
  • Aligning Science Across Parkinson's (000463)
  • Michael J. Fox Foundation for Parkinson's Research (009258)
  • UKRI | Medical Research Council (MC_UU_00018/1)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
LRRK2, Parkinson's disease, dopaminergic neuroprotection, LRRK2 G2019S, cholinergic interneurons, medium spiny neurons, dorsal striatum, glial cell line-derived neurotrophic factor, Rab10 phosphorylation, CNTN5, FTH1, single-nucleus RNA sequencing, cell type specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease. https://app.cochat.ai/papers/10.1073/pnas.2402206121
The paper
Khan, S. S., Jaimon, E., Lin, Y.-E., Nikoloff, J., Tonelli, F., Alessi, D. R., & Pfeffer, S. R. (2024). Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2402206121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.